KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Accumulated Expenses (2016 - 2026)

Edwards Lifesciences has reported Accumulated Expenses over the past 17 years, most recently at $1.6 billion for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 21.78% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 21.78%, while the annual FY2025 figure was $1.6 billion, 21.78% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $1.6 billion at Edwards Lifesciences, up from $1.4 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.7 billion in Q3 2024 and troughed at $739.5 million in Q3 2022.
  • A 5-year average of $1.0 billion and a median of $889.2 million in 2023 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 70.44% in 2024 and later decreased 20.13% in 2025.
  • Year by year, Accumulated Expenses stood at $802.3 million in 2021, then decreased by 0.91% to $795.0 million in 2022, then rose by 7.72% to $856.4 million in 2023, then skyrocketed by 49.74% to $1.3 billion in 2024, then rose by 21.78% to $1.6 billion in 2025.
  • Business Quant data shows Accumulated Expenses for EW at $1.6 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.2 billion in Q2 2025.